Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI Revolution in Radiology, Radiation Oncology and Nuclear Medicine: Transforming and Innovating the Radiological Sciences.

Journal of medical imaging and radiation oncology·2025
Same author

Unidirectional ray polaritons in twisted asymmetric stacks.

Nature communications·2024
Same author

Twist-tunable polaritonic nanoresonators in a van der Waals crystal.

NPJ 2D materials and applications·2024
Same author

Multiple and spectrally robust photonic magic angles in reconfigurable α-MoO<sub>3</sub> trilayers.

Nature materials·2023
Same author

[Clarification of dizziness in old age : Interdisciplinary diagnostic process].

Zeitschrift fur Gerontologie und Geriatrie·2020
Same author

Comprehensive case management of malaria: Operational research informing policy.

Journal of vector borne diseases·2019
Same journal

Decline in Calmette-Guérin Bacillus Vaccination Coverage and Change in the Spatiotemporal Pattern of Extrapulmonary Tuberculosis in Children and Adolescents in Brazil: An Ecological Study, 2004-2023.

Tropical medicine & international health : TM & IH·2026
Same journal

Virological Suppression Rate and Drug Resistance in Children and Adolescents Receiving Dolutegravir-Containing Antiretroviral Therapy in Ndop Health District, Cameroon.

Tropical medicine & international health : TM & IH·2026
Same journal

Resurgence of Typhoid Fever in Ghana: A Scoping Review of Epidemiology, Antimicrobial Resistance Patterns, Geographic Distribution, and Public Health Interventions.

Tropical medicine & international health : TM & IH·2026
Same journal

Eco-Epidemiological Study of Seropositivity Against Rickettsia and Leptospira Agents in Rural Areas of Urabá, Colombia.

Tropical medicine & international health : TM & IH·2026
Same journal

Performance of Tuberculin Skin Testing Compared With Interferon-Gamma Release Assays Foreign-Born Individuals.

Tropical medicine & international health : TM & IH·2026
Same journal

Co-Occurrence of Malaria, Pneumonia, and Diarrheal Disease Among Households: A Cohort Study in Rural Western Uganda.

Tropical medicine & international health : TM & IH·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Optimal dose finding for novel antimalarial combination therapy.

S Duparc1, C Lanza, D Ubben

  • 1Medicines for Malaria Venture, Geneva, Switzerland. duparcs@mmv.org

Tropical Medicine & International Health : TM & IH
|March 8, 2012
PubMed
Summary
This summary is machine-generated.

Optimizing drug doses is crucial for effective malaria combination therapies and preventing resistance. This paper explores challenges in malaria dose studies and proposes factorial designs to overcome them.

More Related Videos

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
08:31

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Published on: October 11, 2019

Related Experiment Videos

Last Updated: May 24, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
08:31

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Published on: October 11, 2019

Area of Science:

  • Malariology
  • Pharmacology
  • Drug Development

Background:

  • The Medicines for Malaria Venture (MMV) convened a meeting to discuss challenges in developing novel malaria combination therapies.
  • Achieving high antimalarial efficacy and preventing drug resistance requires careful dose optimization of combination therapy components.

Purpose of the Study:

  • To outline specific challenges in malaria dose-ranging and dose-optimization studies.
  • To discuss the potential of factorial study designs for addressing these challenges in malaria drug development.

Main Methods:

  • Review of challenges in malaria dose-ranging and dose-optimization studies.
  • Discussion of factorial study designs as a potential solution.

Main Results:

  • Dose optimization is a critical factor for antimalarial efficacy and resistance management.
  • Malaria-specific issues complicate standard dose-ranging and optimization studies.

Conclusions:

  • Factorial study designs may offer a viable approach to optimize malaria combination therapies.
  • Addressing dose optimization challenges is essential for advancing novel antimalarial treatments.